Clinical relevance of expression of B7-H1 and B7-H4 in ovarian cancer.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27073557)

Published in Oncol Lett on March 02, 2016

Authors

Mei Xu1, Bei Zhang1, Meng Zhang1, Yang Liu1, Feng-Ling Yin1, Xia Liu2, Shi-Chao Zhuo2

Author Affiliations

1: Department of Obstetrics and Gynecology, Central Hospital of Xuzhou, Xuzhou, Jiangsu 221009, P.R. China.
2: Department of Pathology, Central Hospital of Xuzhou, Xuzhou, Jiangsu 221009, P.R. China.

Articles cited by this

Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer. Proc Natl Acad Sci U S A (2007) 7.49

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity. Curr Opin Immunol (2012) 7.26

Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance. Acta Histochem (2006) 3.24

The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp Cell Res (2005) 1.73

B7-H4 overexpression in ovarian tumors. Gynecol Oncol (2005) 1.51

The inhibitory role of b7-h4 in antitumor immunity: association with cancer progression and survival. Clin Dev Immunol (2011) 1.20

The immunoinhibitory B7-H1 molecule as a potential target in cancer: killing many birds with one stone. Hematol Oncol Stem Cell Ther (2014) 1.17

B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells. Cell Tissue Res (2013) 1.06

B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration. Acta Histochem (2014) 1.05

Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125. Gynecol Oncol (2011) 1.02

Diagnosis and management of adnexal masses. Am Fam Physician (2009) 0.97

B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer. Oncotarget (2015) 0.95

Blockade of the B7-H1/PD-1 pathway as a basis for combination anticancer therapy. Cancer J (2014) 0.88

Overexpression of B7-H1 correlates with malignant cell proliferation in pancreatic cancer. Oncol Rep (2013) 0.85

B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas. Hum Immunol (2014) 0.83

The value of serum CA125 for the development of virtual follow-up strategies for patients with epithelial ovarian cancer: a retrospective study. J Ovarian Res (2012) 0.80

Preparation and characterization of monoclonal antibody against human B7-H4 molecule. Monoclon Antib Immunodiagn Immunother (2014) 0.78